| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 01/13/1993 | EP0521996A1 Catalytic antibody components |
| 01/12/1993 | US5179018 Mamalian monoclonal antibodies against endotoxin of gram-negative bacteria |
| 01/12/1993 | US5178859 Monoclonal antibodies for binding an antigen of Borrelia and epitopes |
| 01/07/1993 | WO1993000436A1 Papillomavirus l2 protein |
| 01/07/1993 | WO1993000434A1 Capsid forming and cystein modified chimaeric ms2-coat protein |
| 01/07/1993 | WO1993000431A1 Ctl4a receptor, fusion proteins containing it and uses thereof |
| 01/07/1993 | WO1993000367A1 Abrin variants and immunnotoxins |
| 01/07/1993 | WO1993000049A1 Osteogenic factor |
| 01/07/1993 | EP0521348A1 Chimeric antibody with specificity for hepatitis B virus pre-S2 surface antigen and cell line producing same |
| 01/07/1993 | EP0521318A2 Hepatitis C diagnostics and vaccines |
| 01/07/1993 | CA2580812A1 Ctla4 receptor, fusion proteins containing it and uses thereof |
| 01/07/1993 | CA2111683A1 Capsid forming and cystein modified chimaeric ms2-coat protein |
| 01/07/1993 | CA2093790A1 Osteogenic factor |
| 01/06/1993 | CN1067679A Recombinant dha-derived cholera toxin subunit analogs |
| 01/05/1993 | US5177193 In vivo half-life, genetic engineering |
| 12/30/1992 | EP0520158A1 Truncated forms of the hepatocyte growth factor (HGF) receptor |
| 12/23/1992 | WO1992022655A1 Hepatitis c diagnostics and vaccines |
| 12/23/1992 | WO1992022653A1 Method for making humanized antibodies |
| 12/23/1992 | WO1992022644A1 Production of a protein of interest in the milk of a transgenic mammelian |
| 12/23/1992 | WO1992022583A2 Tri- and tetra-valent monospecific antigen-binding proteins |
| 12/23/1992 | WO1992022324A1 Microbially-produced antibody fragments and their conjugates |
| 12/23/1992 | WO1992022323A1 Intercellular adhesion molecule-3 and its binding ligands |
| 12/23/1992 | EP0519866A1 Novel anti-HIV antibodies |
| 12/23/1992 | EP0519554A1 Conjugates of the class II protein of the outer membrane of neisseria meningitidis and of HIV-1 related peptides |
| 12/23/1992 | EP0262192B1 Method and means for producing a protein having the same igg specificity as protein g |
| 12/23/1992 | CA2111108A1 Hepatitis c diagnostics and vaccines |
| 12/23/1992 | CA2110799A1 Microbially-produced antibody fragments and their conjugates |
| 12/23/1992 | CA2110387A1 Intercellular adhesion molecule-3 and its binding ligands |
| 12/20/1992 | CA2071088A1 Conjugates of the class ii protein of the outer membrane of neisseria meningitidis and of hiv-1 related peptides, and vaccines containing same |
| 12/19/1992 | CA2071305A1 Anti-hiv antibodies |
| 12/16/1992 | EP0518587A2 A-C-B proinsulin, method of manufacturing and using same, and intermediates in insulin production |
| 12/16/1992 | EP0518443A1 Recombinant proteins of viruses associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome |
| 12/16/1992 | EP0517853A1 METHOD FOR DETECTION OF $i(BORRELIA BURGDORFERI), PURIFIED ANTIGEN THEREOF AND ANTIBODY CAPABLE OF BINDING THEREWITH |
| 12/16/1992 | EP0517829A1 Improved chimeric toxins |
| 12/16/1992 | EP0517810A1 Hybrid compound purification |
| 12/16/1992 | EP0517805A1 Identification and expression of insect steroid receptor dna sequences |
| 12/16/1992 | EP0517754A1 Antibody constructs with enhanced binding affinity |
| 12/15/1992 | US5171673 Genetic engineering to produce a desired heterologous polypeptides in gram positive bacteria |
| 12/15/1992 | US5171670 Recombinant dna method for production of parathyroid hormone |
| 12/15/1992 | US5171666 Monoclonal antibodies reactive with a cell-surface gylcoprotein expressed on human carcinomas |
| 12/15/1992 | US5171665 Monoclonal antibody to novel antigen associated with human tumors |
| 12/15/1992 | CA1311430C Construction of an igg binding protein to facilitate downstream processing using protein engineering |
| 12/10/1992 | WO1992014818A3 Entomopoxvirus expression system comprising spheroidin or thymidine-kinase sequences |
| 12/10/1992 | WO1992009690A3 Enrichment method for variant proteins with altered binding properties |
| 12/09/1992 | EP0517024A2 Tetravalent bispecific receptors, their preparation and use |
| 12/09/1992 | EP0516718A1 A method and compositions to screen compounds for enhancement of the cholinergic, dopaminergic and serotonergic function |
| 12/09/1992 | EP0516655A1 Carrier-bound recombinant protein, process for producing it and its use as an immunogen and vaccine. |
| 12/09/1992 | CN1019355B Process for minactivin and its use |
| 12/08/1992 | US5169934 Intracellularly cleavable compounds |
| 12/08/1992 | US5169764 Multitrophic and multifunctional chimeric neurotrophic factors, and nucleic acids and plasmids encoding the chimeras |
| 12/08/1992 | US5169628 Vaccines |
| 12/08/1992 | CA1311192C Tumor specific assay for ca125 ovarian cancer antigen |
| 12/07/1992 | WO1992021759A1 Nucleotide and peptide sequences of an isolate of the hepatitis c virus, diagnostic and therapeutic applications thereof |
| 12/07/1992 | CA2088666A1 Nucleotide and peptide sequences of hepatitis c virus isolate, diagnostic and therapeutic applications |
| 12/04/1992 | CA2070233A1 Tetravalent bispecific receptors, the preparation and use thereof |
| 12/02/1992 | EP0515569A1 Calcium channel compositions and methods |
| 12/02/1992 | EP0515536A1 Methods and products for the synthesis of oligosaccharide structures on glycoproteins, glycolipids, or as free molecules |
| 12/02/1992 | EP0515527A1 Method for producing antibody-enzyme conjugates |
| 12/02/1992 | EP0515516A1 Totally synthetic affinity reagents |
| 12/02/1992 | EP0515394A1 COVALENT ANGIOGENIN/RNase HYBRIDS |
| 12/01/1992 | US5168063 Strong binding of outer membrane protein; medical diagnosis |
| 12/01/1992 | US5168049 Production of streptavidin-like polypeptides |
| 12/01/1992 | CA1311086C Chimeric peptides for neuropeptide delivery through the blood-brain barrier |
| 11/26/1992 | WO1992020795A1 INHIBITOR OF NF-λB TRANSCRIPTIONAL ACTIVATOR AND USES THEREOF |
| 11/26/1992 | WO1992020792A1 Truncated forms of the hepatocyte growth factor (hgf) receptor |
| 11/26/1992 | WO1992020791A1 Methods for producing members of specific binding pairs |
| 11/26/1992 | WO1992020701A2 Interleukin receptor targeted molecules for treatment of accelerated atherosclerosis |
| 11/26/1992 | WO1992020365A1 Therapeutic and diagnostic methods based on neurotrophin-4 expression |
| 11/26/1992 | CA2109598A1 Therapeutic and diagnostic methods based on neurotrophin-4- expression |
| 11/26/1992 | CA2102704A1 Inhibitor of nf-kb transcriptional activator and uses thereof |
| 11/25/1992 | EP0514481A1 Merosin, nucleic acids encoding, fragments and uses thereof |
| 11/25/1992 | EP0514413A1 Immunologically active peptides or polypeptides from the parvovirus b19. |
| 11/25/1992 | EP0514411A1 Polypeptides and dna encoding same, associated with human malaria parasites |
| 11/25/1992 | EP0139676B1 Production and characterization of hybridoma antibodies directed specifically against common determinant(s) present among closely related, but distinct proteins |
| 11/24/1992 | US5166063 Immobolization of biomolecules by enhanced electrophoretic precipitation |
| 11/24/1992 | US5166057 Templates for gene expression |
| 11/19/1992 | EP0514173A2 Methods and compositions for enzyme complementation assays using the omega region of beta-galactosidase |
| 11/19/1992 | EP0513242A1 Lipopolysaccharide binding opsonin and methods of use thereof |
| 11/19/1992 | EP0513090A1 Hepatitis a vaccines |
| 11/19/1992 | EP0513073A1 PROCESS FOR ENZYMATICAL CLEAVAGE OF RECOMBINANT PROTEINS BY MEANS OF IgA PROTEASES. |
| 11/18/1992 | WO1992020364A1 Cytokine receptor targeted molecules for treatment of meoplastic cell growth |
| 11/18/1992 | CN1066272A Process for preparation of anti-thrombin polypeptides |
| 11/18/1992 | CA2103258A1 Cytokine receptor targeted molecules for treatment of neoplastic cell growth |
| 11/17/1992 | US5164311 Preparation of an antibody-enzyme conjugate |
| 11/15/1992 | WO1992020373A1 Heteroconjugate antibodies for treatment of hiv infection |
| 11/15/1992 | CA2102511A1 Heteroconjugate antibodies for treatment of hiv infection |
| 11/12/1992 | WO1992019969A1 Immunoassay for detecting group b streptococcus |
| 11/12/1992 | WO1992019759A1 Reconstituted human antibody against human interleukin 6 receptor |
| 11/12/1992 | WO1992019735A1 GLYCAM-1 (Sgp 50), A SELECTIN LIGAND |
| 11/12/1992 | WO1992019734A1 Binding domains in notch and delta proteins |
| 11/12/1992 | WO1992019649A1 Antigens recognized by antibodies of rhumatoid polyarthritis, and preparation and use thereof |
| 11/12/1992 | CA2109090A1 Immunoassay for detecting group b streptococcus |
| 11/12/1992 | CA2108029A1 Glycam-1(sgp 50), a selectin ligand |
| 11/12/1992 | CA2084876A1 Antigens specifically recognized by specific antibodies of rheumatoid arthritis, their constituent proteins, preparation and applications |
| 11/11/1992 | EP0511978A1 Method of purifying recombinant polypeptides. |
| 11/04/1992 | EP0511747A1 Hybrid polypeptide containing an avidin binding polypeptide |
| 11/04/1992 | EP0511300A1 Monoclonal antibody specific for non-immunodominant epitope of hiv proteins |
| 11/04/1992 | EP0229782B1 Methods for identifying alleles associated with increased risk of diabetes |
| 11/03/1992 | WO1992019265A1 Recombinant dna-derived cholera toxin subunit analogs |
| 11/03/1992 | CA2102105A1 Recombinant dna-derived cholera toxin subunit analogs |